DUBLIN, IRELAND -- (Marketwired) -- 11/04/15 -- Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, announced today that the company will be presenting at the following conferences in November:

Stifel 2015 Healthcare Conference

• Presentation Date: November 18, 2015
• Presentation Time: 10:15 a.m. EST
• Location: New York

Jefferies Autumn 2015 Global Healthcare Conference

• Presentation Date: November 19, 2015
• Presentation Time: 5 a.m. EST/10 a.m. GMT
• Location: London

Goldman Sachs US Emerging & SMID Cap Growth Conference

• Presentation Date: November 19, 2015
• Presentation Time: 9:20 a.m. EST
• Location: New York

The presentations will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizon-pharma.com. A replay of the webcast will be available following each of the events.

About Horizon Pharma plc Horizon Pharma plc is a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs. The Company markets seven medicines through its orphan, primary care and specialty business units. Horizon Pharma's global headquarters are in Dublin, Ireland. For more information, please visit www.horizonpharma.com. Follow @HZNPplc on Twitter or view careers on our LinkedIn page.

Contacts:

Investors:
John Thomas
Executive Vice President, Corporate Strategy and Investor Relations
[email protected]

Tina Ventura
Vice President, Investor Relations
[email protected]

Media:
Geoff Curtis
Group Vice President, Corporate Communications
[email protected]

Source: Horizon Pharma plc